Baupost Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,950,000
Closed -$133M 38
2022
Q3
$133M Sell
2,950,000
-758,150
-20% -$37.9M 2.3% 16
2022
Q2
$165M Sell
3,708,150
-62,850
-2% -$3.22M 2.44% 14
2022
Q1
$213M Buy
3,771,000
+2,870,862
+319% +$150M 2.29% 16
2021
Q4
$46.7M Buy
+900,138
New +$46.4M 0.46% 28

Other funds holding EHC

Baupost Group's EHC Position: Q4 2022 in Review

Baupost Group sold out of Encompass Health (EHC) in Q4 2022, closing a stake of 2,950,000 shares — an estimated $133M sold.

Baupost Group first reported a position in EHC in Q4 2021 and held it in 4 quarters. The position peaked at $213M in Q1 2022. 377 funds tracked by Wall St. Rank hold EHC as of Q4 2022.

  • Baupost Group reported no remaining Encompass Health position as of Q4 2022 after selling out during the quarter.
  • Baupost Group sold 2,950,000 Encompass Health shares in Q4 2022, an estimated $133M.
  • Baupost Group first reported a position in Encompass Health in Q4 2021 and held it in 4 quarters.
  • Baupost Group's Encompass Health position peaked at $213M in Q1 2022.
  • 377 funds tracked by Wall St. Rank held Encompass Health as of Q4 2022.

Based on Baupost Group's 13F filing for Q4 2022, filed 13 Feb 2023.